Eden Research (LON:EDEN) Stock Price Down 3.3% – Time to Sell?

Posted by Jeff Wilder on Feb 21st, 2025

Eden Research plc (LON:EDEN – Get Free Report)’s share price fell 3.3% during mid-day trading on Friday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares traded hands during mid-day trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Stock Down 3.3 %

The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42. The stock has a market cap of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92. The firm’s 50-day moving average is GBX 3.88 and its 200 day moving average is GBX 3.95.

Insider Buying and Selling

In other news, insider Lykele van der Broek bought 256,000 shares of the firm’s stock in a transaction dated Thursday, February 6th. The stock was acquired at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,975.16). Also, insider Alexander John Abrey purchased 540,540 shares of the business’s stock in a transaction that occurred on Tuesday, January 28th. The stock was acquired at an average price of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,396.86). Corporate insiders own 14.02% of the company’s stock.

Eden Research Company Profile

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.